MetaADEDB 2.0 @ LMMD
Colistin
(YKQOSKADJPQZHB-QNPLFGSASA-N)
Structure
SMILES
NCC[C@@H](C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CCN)CC(C)C)CC(C)C)CCN)[C@H](O)C)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)CCCC(CC)C)CCN
Molecular Formula:
C52H98N16O13
Molecular Weight:
1155.430
Log P:
1.5352
Hydrogen Bond Acceptor:
29
Hydrogen Bond Donor:
18
TPSA:
490.66
CAS Number(s):
1066-17-7
Synonym(s)
1.
Colistin
2.
Polymyxin E
3.
Colimycin
4.
Colisticin
5.
Colistin Sulfate
6.
Coly-Mycin
7.
Totazina
8.
Sulfate, Colistin
External Link(s)
MeSHD003091
PubChem Compound5311054
CHEMBLCHEMBL499783
Therapeutic Target DatabaseD0K7NQ
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug resistanceFAERS: 7OFFSIDES
US FAERS
2Acinetobacter test positiveFAERS: 2US FAERS
3Acute kidney injuryFAERS: 2
Canada Vigilance: 1
24189134CTD
Canada Vigilance
US FAERS
4Blood creatinine increasedFAERS: 2OFFSIDES
US FAERS
5ChillsFAERS: 1US FAERS
6Drug ineffectiveFAERS: 1US FAERS
7HypercreatinaemiaFAERS: 1US FAERS
8Lower respiratory tract infectionFAERS: 1US FAERS
9Multi-organ disorderFAERS: 1OFFSIDES
US FAERS
10PneumothoraxFAERS: 1US FAERS
11PregnancyFAERS: 1US FAERS
12Respiratory DepressionFAERS: 1US FAERS
13Rhinovirus infectionFAERS: 1US FAERS
14SepsisFAERS: 1US FAERS
15SomnolenceFAERS: 1US FAERS
16Abdominal discomfortOFFSIDES
17Accidental deathCanada Vigilance: 1Canada Vigilance
18Anterior chamber flareOFFSIDES
19AppendectomyOFFSIDES
20AppendicitisOFFSIDES
21BlepharitisOFFSIDES
22Brain Diseases4615135CTD
23Brain Injuries30138604CTD
24Burkholderia cepacia InfectionOFFSIDES
25Chronic Obstructive Airway DiseaseOFFSIDES
26Conjunctival depositOFFSIDES
27Cystic Fibrosis19747007CTD
28Cystitis1009330CTD
29Cytolytic hepatitisOFFSIDES
30Cytomegalovirus hepatitisOFFSIDES
31Deafness646445CTD
32Edema30138604CTD
33Erosive gastritisOFFSIDES
34Escherichia coli Infections1107297CTD
35Extravasation of Diagnostic and Therapeutic Materials31132327CTD
36Eye painOFFSIDES
37Eyelid infectionOFFSIDES
38Gamma-Glutamyltransferase IncreasedOFFSIDES
39GastroenteritisOFFSIDES
40Gastrointestinal toxicityOFFSIDES
41Gram-Negative Bacterial Infections28842171CTD
42Hepatic artery thrombosisOFFSIDES
43HepatotoxicityOFFSIDES
44Hypocalcemia646445CTD
45Hypokalemia646445CTD
46Kidney Diseases30138604CTD
47Klebsiella Infections1107297
4615135
CTD
48Metabolic acidosisOFFSIDES
49Necrosis30138604CTD
50Nerve Degeneration28465020CTD
51Neurotoxicity Syndromes28842171CTD
52Neutropenic colitisOFFSIDES
53Neutropenic sepsisOFFSIDES
54Non-cardiac chest painOFFSIDES
55Ophthalmoplegia4615135CTD
56Osteomyelitis4615135CTD
57Pathogen resistanceOFFSIDES
58Post procedural bile leakOFFSIDES
59PruritusCanada Vigilance: 1Canada Vigilance
60Pseudomonas Infections1107297CTD
61Renal cystOFFSIDES
62Respiratory FailureOFFSIDES
63Retinal exudatesOFFSIDES
64Retinal infarctionOFFSIDES
65Retinal scarOFFSIDES
66ScotomaOFFSIDES
67Sensation Disorders5579509CTD
68Septic ShockOFFSIDES
69Tetany646445CTD
70VitrectomyOFFSIDES
71bone marrow fibrosisOFFSIDES
72treatment failureOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.